Hengkang Medical Group Co Ltd
New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as tumors, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiw… Read more
Hengkang Medical Group Co Ltd (002219) - Net Assets
Latest net assets as of September 2025: CN¥2.02 Billion CNY
Based on the latest financial reports, Hengkang Medical Group Co Ltd (002219) has net assets worth CN¥2.02 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥6.55 Billion) and total liabilities (CN¥4.53 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.02 Billion |
| % of Total Assets | 30.87% |
| Annual Growth Rate | 18.19% |
| 5-Year Change | 1192.93% |
| 10-Year Change | -46.34% |
| Growth Volatility | 202.64 |
Hengkang Medical Group Co Ltd - Net Assets Trend (2004–2024)
This chart illustrates how Hengkang Medical Group Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Hengkang Medical Group Co Ltd (2004–2024)
The table below shows the annual net assets of Hengkang Medical Group Co Ltd from 2004 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.04 Billion | -8.67% |
| 2023-12-31 | CN¥2.23 Billion | +26.57% |
| 2022-12-31 | CN¥1.77 Billion | +11.31% |
| 2021-12-31 | CN¥1.59 Billion | +904.86% |
| 2020-12-31 | CN¥157.84 Million | -23.94% |
| 2019-12-31 | CN¥207.51 Million | -92.74% |
| 2018-12-31 | CN¥2.86 Billion | -34.27% |
| 2017-12-31 | CN¥4.35 Billion | +4.19% |
| 2016-12-31 | CN¥4.17 Billion | +9.72% |
| 2015-12-31 | CN¥3.80 Billion | +260.35% |
| 2014-12-31 | CN¥1.06 Billion | +28.57% |
| 2013-12-31 | CN¥820.80 Million | +46.40% |
| 2012-12-31 | CN¥560.65 Million | +17.50% |
| 2011-12-31 | CN¥477.16 Million | +15.21% |
| 2010-12-31 | CN¥414.18 Million | +16.81% |
| 2009-12-31 | CN¥354.57 Million | +13.65% |
| 2008-12-31 | CN¥311.99 Million | +118.60% |
| 2007-12-31 | CN¥142.72 Million | +31.03% |
| 2006-12-31 | CN¥108.93 Million | +21.48% |
| 2005-12-31 | CN¥89.67 Million | +24.38% |
| 2004-12-31 | CN¥72.09 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Hengkang Medical Group Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 15880.5% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CN¥3.39 Billion | 170.65% |
| Other Components | CN¥1.56 Billion | 78.63% |
| Total Equity | CN¥1.98 Billion | 100.00% |
Hengkang Medical Group Co Ltd Competitors by Market Cap
The table below lists competitors of Hengkang Medical Group Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shen Zhen Bauing Construction Holding Group Co Ltd
SHE:002047
|
$693.11 Million |
|
Leopalace21 Corporation
F:MQI
|
$693.13 Million |
|
State Power Rixin Technology Co. Ltd.
SHE:301162
|
$693.14 Million |
|
Shenzhen Changhong Tech
SHE:300151
|
$693.14 Million |
|
BIRLASOFT LIMITED
NSE:BSOFT
|
$692.71 Million |
|
Zhangjiagang Furui Special Equip
SHE:300228
|
$692.46 Million |
|
Scholastic Corporation
NASDAQ:SCHL
|
$692.35 Million |
|
PORR AG
VI:POS
|
$692.13 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Hengkang Medical Group Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,195,689,411 to 1,984,979,266, a change of -210,710,145 (-9.6%).
- Net income of 114,765,529 contributed positively to equity growth.
- Dividend payments of 118,236,738 reduced retained earnings.
- Share repurchases of 55,320,593 reduced equity.
- Other factors decreased equity by 151,918,343.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥114.77 Million | +5.78% |
| Dividends Paid | CN¥118.24 Million | -5.96% |
| Share Repurchases | CN¥55.32 Million | -2.79% |
| Other Changes | CN¥-151.92 Million | -7.65% |
| Total Change | CN¥- | -9.60% |
Book Value vs Market Value Analysis
This analysis compares Hengkang Medical Group Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.08x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 17.46x to 4.08x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | CN¥0.14 | CN¥2.46 | x |
| 2005-12-31 | CN¥0.18 | CN¥2.46 | x |
| 2006-12-31 | CN¥0.22 | CN¥2.46 | x |
| 2007-12-31 | CN¥0.20 | CN¥2.46 | x |
| 2008-12-31 | CN¥0.35 | CN¥2.46 | x |
| 2009-12-31 | CN¥0.24 | CN¥2.46 | x |
| 2010-12-31 | CN¥0.28 | CN¥2.46 | x |
| 2011-12-31 | CN¥0.32 | CN¥2.46 | x |
| 2012-12-31 | CN¥0.36 | CN¥2.46 | x |
| 2013-12-31 | CN¥0.52 | CN¥2.46 | x |
| 2014-12-31 | CN¥0.66 | CN¥2.46 | x |
| 2015-12-31 | CN¥2.14 | CN¥2.46 | x |
| 2016-12-31 | CN¥2.16 | CN¥2.46 | x |
| 2017-12-31 | CN¥2.24 | CN¥2.46 | x |
| 2018-12-31 | CN¥1.45 | CN¥2.46 | x |
| 2019-12-31 | CN¥0.10 | CN¥2.46 | x |
| 2020-12-31 | CN¥0.07 | CN¥2.46 | x |
| 2021-12-31 | CN¥0.83 | CN¥2.46 | x |
| 2022-12-31 | CN¥0.53 | CN¥2.46 | x |
| 2023-12-31 | CN¥0.65 | CN¥2.46 | x |
| 2024-12-31 | CN¥0.60 | CN¥2.46 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Hengkang Medical Group Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.78%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.02%
- • Asset Turnover: 0.57x
- • Equity Multiplier: 3.36x
- Recent ROE (5.78%) is above the historical average (-55.74%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 19.04% | 16.35% | 0.55x | 2.12x | CN¥6.52 Million |
| 2005 | 19.60% | 17.54% | 0.64x | 1.76x | CN¥8.61 Million |
| 2006 | 17.68% | 14.80% | 0.69x | 1.72x | CN¥8.37 Million |
| 2007 | 23.68% | 17.05% | 0.84x | 1.66x | CN¥19.52 Million |
| 2008 | 14.27% | 15.62% | 0.79x | 1.15x | CN¥13.31 Million |
| 2009 | 13.48% | 16.77% | 0.63x | 1.28x | CN¥12.35 Million |
| 2010 | 15.93% | 22.04% | 0.58x | 1.24x | CN¥24.54 Million |
| 2011 | 14.95% | 23.22% | 0.51x | 1.26x | CN¥23.63 Million |
| 2012 | 13.53% | 21.86% | 0.39x | 1.60x | CN¥19.22 Million |
| 2013 | 21.15% | 30.07% | 0.49x | 1.42x | CN¥89.51 Million |
| 2014 | 25.20% | 37.53% | 0.36x | 1.85x | CN¥155.22 Million |
| 2015 | 8.68% | 27.39% | 0.25x | 1.28x | CN¥-49.07 Million |
| 2016 | 9.88% | 18.56% | 0.36x | 1.47x | CN¥-4.86 Million |
| 2017 | 4.84% | 5.97% | 0.33x | 2.45x | CN¥-216.05 Million |
| 2018 | -52.30% | -36.94% | 0.44x | 3.23x | CN¥-1.69 Billion |
| 2019 | -1293.40% | -68.38% | 0.75x | 25.20x | CN¥-2.54 Billion |
| 2020 | -39.03% | -1.86% | 0.58x | 36.02x | CN¥-65.63 Million |
| 2021 | -23.92% | -12.32% | 0.45x | 4.31x | CN¥-526.74 Million |
| 2022 | 9.06% | 4.94% | 0.56x | 3.27x | CN¥-16.19 Million |
| 2023 | 1.32% | 0.74% | 0.64x | 2.77x | CN¥-190.60 Million |
| 2024 | 5.78% | 3.02% | 0.57x | 3.36x | CN¥-83.73 Million |
Industry Comparison
This section compares Hengkang Medical Group Co Ltd's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $3,066,061,955
- Average return on equity (ROE) among peers: 8.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Hengkang Medical Group Co Ltd (002219) | CN¥2.02 Billion | 19.04% | 2.24x | $692.82 Million |
| Xian International Medical Investment Co Ltd (000516) | $3.50 Billion | 5.76% | 0.59x | $1.03 Billion |
| Meinian Onehealth Healthcare Holdings Co Ltd (002044) | $347.62 Million | 6.68% | 0.24x | $2.93 Billion |
| Aier Eye Hospital Group (300015) | $12.22 Billion | 19.01% | 0.79x | $5.88 Billion |
| Liaoning He Eye Hospital Group Co. LTD. (301103) | $1.88 Billion | -1.46% | 0.18x | $159.92 Million |
| Chengdu Bright Eye Hospital Co. Ltd. (301239) | $2.12 Billion | -4.80% | 1.17x | $342.22 Million |
| Huaxia Eye Hospital Group Co. Ltd. A (301267) | $1.85 Billion | 24.61% | 0.74x | $385.79 Million |
| Sanbo Hospital Management Group Ltd. A (301293) | $2.51 Billion | 3.12% | 0.25x | $1.52 Billion |
| Top Choice Medical Investment Co Inc (600763) | $100.20 Million | 13.53% | 0.09x | $1.69 Billion |